| Execution period | Quarter ended 31st March, 2026 |
|---|
NSE filing, NSE: MONOLITH. Summary written from the filing by ALFA Finder's alert engine.
Monolithisch India Ltd: key numbers
- Share price
- ₹1,281.20
- Market cap
- ₹2,785 Cr
- Revenue (annual)
- ₹135.3 Cr
- Net profit (annual)
- ₹23.03 Cr
- P/E (TTM)
- 120.9×Sector 52.2×
- Promoter holding
- 74.57%+0.30% QoQ
- FII holding
- 1.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Monolithisch India Ltd
All →Monolithisch India Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹53.6 Cr (+88.2% YoY), EBITDA ₹15.8 Cr (29.5% margin), PAT ₹11.2 Cr (+145.1%), driven by SGB Limited premiumisation and 5.76 lakh MTPA scale.
Monolithisch India Results Update
Monolithisch India reported record Q2 FY27 revenue of ₹53.59 crore, up 88.2%. Its greenfield facility began commercial production on October 10, 2026.
Monolithisch India Q2 FY27 Results: Net Profit ₹11.2 Cr, Up 143.5% YoY
Monolithisch India Ltd reported revenue from operations of ₹53.6 Cr (+88.1% YoY) and net profit of ₹11.2 Cr (+143.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹11.2 Cr · +143.5% YoY
Monolithisch India Board Meeting Date
Monolithisch India Limited has scheduled a board meeting for October 24, 2026. The board will consider half-yearly unaudited financial results for the period ended September 2026.
Monolithisch India Earnings Call Transcript: Key Takeaways
Transcript of Q2 FY27 investor call discussing strategic expansion and backward integration. Management focuses on significant cost savings from new captive mining assets and multi-region capacity growth.
Monolithisch India Annual General Meeting
Monolithisch India Limited successfully concluded its 8th Annual General Meeting on September 29, 2026. The meeting transacted all ordinary business items as per the notice.
Other other announcement announcements
All →Prism Medico and Pharmacy Other Announcement
Prism Medico and Pharmacy intimated BSE and MSEI that its corporate website is updated and functional per Regulation 46. This is a routine compliance undertaking with no financial impact.
Banaras Beads Other Announcement
Banaras Beads Ltd filed its half-year related-party transaction disclosure under Listing Regulation 23(9). The filing reports routine remuneration and sitting fees to promoters and directors.
Gita Renewable Energy Other Announcement
Gita Renewable Energy intimated a change in its CIN after altering its Objects Clause. The change followed a Special Resolution at its 16th AGM.
Indian Toners & Developers Other Announcement
Indian Toners & Developers has intimated that NSE approved listing of its 5.19 crore equity shares (₹2 face value) on the NSE Mainboard effective October 30, 2026. This is an additional-exchange admission of already-issued BSE-listed shares.
Indian Phosphate Other Announcement
Indian Phosphate filed a Reg 27(2) governance non-applicability certificate for Q1 FY2027. The routine compliance filing carries no transaction or financial impact.
Neuland Laboratories Other Announcement
Neuland Laboratories notified loss of 100 share certificates by shareholder Madan Mohan Singh. The company requested issuance of an entitlement letter in lieu of the lost certificates.